2010

Baccarani, U., P. Piselli, D. Serraino, G. L. Adani, D. Lorenzin, M. Gambato et al. (2010). “Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.” eng. In: Dig Liver Dis 42.1, pp. 55–60.

Burra, P., G. Germani, A. Masier, E. De Martin, M. Gambato, A. Salonia et al. (2010). “Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure?” eng. In: Transplantation 89.12, pp. 1425–9.

Campagna, F., A. Biancardi, U. Cillo, A. Gatta e P. Amodio (2010). “Neurocognitiveneurological complications of liver transplantation: a review.” eng. In: Metab Brain Dis 25.1, pp. 115–24.

Carraro, A., M. Flaibani, U. Cillo, L. Michelotto, E. Magrofuoco, M. Buggio et al. (2010). “A combining method to enhance the in vitro differentiation of hepatic precursor cells.” eng. In: Tissue Eng Part C Methods 16.6, pp. 1543–51.

Cillo, U., A. Vitale, M. L. Volk, A. C. Frigo, F. Grigoletto, A. Brolese et al. (2010). “The survival benefit of liver transplantation in hepatocellular carcinoma patients.” eng. In: Dig Liver Dis 42.9, pp. 642–9.

Croce, A. C., U. De Simone, I. Freitas, E. Boncompagni, D. Neri, U. Cillo e G. Bottiroli (2010). “Human liver autofluorescence: an intrinsic tissue parameter discriminating normal and diseased conditions.” eng. In: Lasers Surg Med 42.5, pp. 371–8.

Cucchetti, A., A. Vitale, M. D. Gaudio, M. Ravaioli, G. Ercolani, M. Cescon et al. (2010). “Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma.” eng. In: Am J Transplant 10.3, pp. 619–27.

Feltracco, P., S. Barbieri, M. Furnari, M. Milevoj, S. Rizzi, H. Galligioni et al. (2010). “Central nervous system infectious complications early after liver transplantation.” eng. In: Transplant Proc 42.4, pp. 1216–22.

Gringeri, E., A. Carraro, E. Tibaldi, F. E. D’Amico, M. Mancon, A. Toninello et al. (2010). “Lyn-mediated mitochondrial tyrosine phosphorylation is required to preserve mitochondrial integrity in early liver regeneration.” eng. In: Biochem J 425.2, pp. 401–12.

Polacco, M., A. Vitale, M. Valmasoni, F. D’Amico, E. Gringeri, A. Brolese et al. (2010). “Liver resection associated with mini porto-caval shunt as salvage treatment in patients with progression of hepatocellular carcinoma before liver transplantation: a case report.” eng. In: Transplant Proc 42.4, pp. 1378–80.

Schnitzbauer, A. A., C. Zuelke, C. Graeb, J. Rochon, I. Bilbao, P. Burra et al. (2010). “A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.” eng. In: BMC Cancer 10, p. 190.

Vitale, A., M. L. Volk, M. Gambato, G. Zanus, F. D’Amico, A. Carraro et al. (2010a). “Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation.” eng. In: Transplant Proc 42.4, pp. 1194–6